Trial HoldingsTSE:141A -1.94%9 ROE % is 15.99% as of Dec. 2025, which is 27% above its 10-year median of 12.60. GuruFocus rates TSE:141A with a GF Score™ of 9/100. The stock has 5 warning signs investors should review. Among 306 Retail - Defensive companies, Trial Holdings ranks worse than 55.56% on this metric.
ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Trial Holdings's annualized net income for the quarter that ended in Dec. 2025 was 円20,144 Mil. Trial Holdings's average Total Stockholders Equity over the quarter that ended in Dec. 2025 was 円125,973 Mil. Therefore, Trial Holdings's annualized ROE % for the quarter that ended in Dec. 2025 was 15.99%.
The historical rank and industry rank for Trial Holdings's ROE % or its related term are showing as below:
TSE:141A'
s ROE % Range Over the Past 10 Years
Min: 3.59 Med: 12.6 Max: 13.06
Current: 7.36
During the past 5 years, Trial Holdings's highest ROE % was 13.06%. The lowest was 3.59%. And the median was 12.60%.
TSE:141A's ROE % is ranked worse than 55.56% of 306
companies
in the Retail - Defensive industry
Industry Median: 8.57
vs TSE:141A: 7.36
Trial Holdings (TSE:141A) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Dec. 2025) net income data. The Revenue data used here is four times the quarterly (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Trial Holdings ROE % Related Terms
Trial Holdings ROE % Historical Data
* Premium members only.
The historical data trend for Trial Holdings's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Discount Stores subindustry, Trial Holdings's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Trial Holdings ROE % vs Retail - Defensive Industry
For the Retail - Defensive industry and Consumer Defensive sector, Trial Holdings's ROE % distribution charts can be found below:
* The bar in red indicates where Trial Holdings's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Dec. 2025) net income data.
ROE % is displayed in the 30-year financial page.
Trial Holdings (TSE:141A) has a ROE % of 15.99% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Trial Holdings and its competitors. This is 27% above median its historical median of 12.60. Over the past decade, Trial Holdings' ROE % has ranged from 3.59 to 13.06. According to the industry distribution chart, Trial Holdings ranks #170 out of 306 companies in the Retail - Defensive industry, placing it in the top 55.6%.
Is Trial Holdings' ROE % too high?
Trial Holdings' current ROE % of 15.99% is 27% above median its 10-year median of 12.60. Over the past 10 years, this metric has ranged from a low of 3.59 to a high of 13.06. The Retail - Defensive industry median ROE % is 8.57. Trial Holdings' value of 15.99% is 86.6% above this industry median. Based on the distribution chart, Trial Holdings ranks #170 out of 306 companies in the Retail - Defensive industry, which is below the industry midpoint. Overall, Trial Holdings has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Trial Holdings' ROE % compare to WMT and COST?
According to the Retail - Defensive industry distribution chart, Trial Holdings ranks #170 out of 306 companies for ROE %. This places Trial Holdings in the lower half of its industry. The industry median ROE % is 8.57. Trial Holdings' value of 15.99% is 86.6% above this benchmark. Historically, Trial Holdings' own ROE % has ranged from 3.59 to 13.06 over the past decade. While the company's 10-year median is 12.60 vs. the industry median of 8.57, Trial Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Retail - Defensive company?
The median ROE % among Retail - Defensive companies is 8.57, based on 306 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Trial Holdings's current ROE % of 15.99% is 86.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Trial Holdings and its competitors. For the Retail - Defensive industry, the median ROE % is 8.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Trial Holdings's current ROE % is 15.99%, which is 27% above median its own 10-year median of 12.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trial Holdings stock overvalued right now?
Trial Holdings (TSE:141A) has a current ROE % of 15.99%. The current ROE % is 15.99%, which is 27% above median its 10-year median of 12.60 and 86.6% above the Retail - Defensive industry median of 8.57. Trial Holdings' overall GF Score™ is 9/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Trial Holdings (TSE:141A), the current ROE % is 15.99% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Trial Holdings Inc is a holding company. Along with its subsidiaries, it operates in the following reportable segments: Retail Distribution Business and Retail AI Business. The majority of its revenue is generated from the Retail Distribution Business, which operates discount stores across Japan, ranging from small to large, along with medium-sized supercenters. The product lineup of the stores focuses on food (especially fresh foods), and non-food items include daily necessities and hard goods. The Retail AI Business segment is mainly involved in research and development aimed at transforming stores into smart stores, as well as the sale of products and the outsourcing of services related to smart stores. In addition, the group is involved in real estate and resort-related businesses.
9GF Score
Get the complete analysis for TSE:141A
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:141A has been successfully added to your 
